- Corporate Officers - T
- Tessier-lavigne Marc
Insider Trading History of Tessier-lavigne Marc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Tessier-lavigne Marc since 2008.
This trader's CIK number is 1437435.
At the time of last reporting, Tessier-lavigne Marc was the Officer of Denali Therapeutics Inc.. (stock ticker symbol DNLI).
Also see all insider trading activities at Denali Therapeutics Inc..
Note that in the past
Tessier-Lavigne Marc also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Agios Pharmaceuticals, Inc. (AGIO) by Tessier-lavigne Marc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | AGIO | 55,555 | $999,990 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Genentech Inc (DNA) by Tessier-lavigne Marc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | DNA | 0 | $0 | 18,750 | $1,498,125 | 18,750 | $998,062 |
Yearly summary of insider trading at Denali Therapeutics Inc. (DNLI) by Tessier-lavigne Marc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | DNLI | 0 | $0 | 100,000 | $3,261,100 | 0 | $0 |
| 2021 | DNLI | 0 | $0 | 213,131 | $12,579,757 | 0 | $0 |
| 2020 | DNLI | 0 | $0 | 400,000 | $10,440,000 | 0 | $0 |
Yearly summary of insider trading at Regeneron Pharmaceuticals, Inc. (REGN) by Tessier-lavigne Marc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | REGN | 0 | $0 | 30,468 | $21,024,909 | 30,468 | $11,894,575 |
| 2021 | REGN | 0 | $0 | 16,534 | $10,732,906 | 16,534 | $4,894,669 |
| 2020 | REGN | 0 | $0 | 29,279 | $14,171,304 | 29,279 | $3,438,508 |
| 2015 | REGN | 0 | $0 | 5,000 | $2,954,150 | 5,000 | $285,550 |
| 2014 | REGN | 0 | $0 | 3,000 | $1,056,600 | 4,387 | $223,342 |
| 2013 | REGN | 0 | $0 | 13,334 | $3,494,934 | 13,334 | $747,730 |
Insider trading activities at 4 companies by Tessier-lavigne Marc:
1. Agios Pharmaceuticals, Inc. (AGIO)
2. Genentech Inc (DNA)
3. Denali Therapeutics Inc. (DNLI)
4. Regeneron Pharmaceuticals, Inc. (REGN)
Table 1. Insider trading of Agios Pharmaceuticals, Inc. (AGIO) by Tessier-lavigne Marc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-07-24 | AGIO | Buy | 55,555 | 18.00 | 999,990 |
Table 2. Insider trading of Genentech Inc (DNA) by Tessier-lavigne Marc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-07-16 | DNA | Option Ex | 18,750 | 53.23 | 998,062 |
| 2008-07-16 | DNA | Sale | 18,750 | 79.90 | 1,498,125 |
Table 3. Insider trading of Denali Therapeutics Inc. (DNLI) by Tessier-lavigne Marc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-11-23 | DNLI | Sale | 20,000 | 30.48 | 609,600 |
| 2022-09-28 | DNLI | Sale | 20,000 | 30.91 | 618,200 |
| 2022-08-23 | DNLI | Sale | 20,000 | 32.02 | 640,400 |
| 2022-07-25 | DNLI | Sale | 20,000 | 35.88 | 717,500 |
| 2022-03-23 | DNLI | Sale | 20,000 | 33.77 | 675,400 |
| 2021-12-28 | DNLI | Sale | 10,980 | 44.37 | 487,215 |
| 2021-12-29 | DNLI | Sale | 32,104 | 43.88 | 1,408,627 |
| 2021-12-30 | DNLI | Sale | 20,047 | 45.46 | 911,376 |
| 2021-05-21 | DNLI | Sale | 37,957 | 60.13 | 2,282,468 |
| 2021-05-24 | DNLI | Sale | 8,806 | 60.02 | 528,580 |
| 2021-05-03 | DNLI | Sale | 3,237 | 60.64 | 196,291 |
| 2021-03-01 | DNLI | Sale | 100,000 | 67.65 | 6,765,200 |
| 2020-06-16 | DNLI | Sale | 400,000 | 26.10 | 10,440,000 |
Table 4. Insider trading of Regeneron Pharmaceuticals, Inc. (REGN) by Tessier-lavigne Marc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-09-30 | REGN | Sale | 3,428 | 698.00 | 2,392,744 |
| 2022-09-29 | REGN | Sale | 3,798 | 694.51 | 2,637,764 |
| 2022-10-03 | REGN | Sale | 3,612 | 718.00 | 2,593,416 |
| 2022-09-30 | REGN | Option Ex | 3,428 | 413.33 | 1,416,895 |
| 2022-09-29 | REGN | Option Ex | 3,798 | 413.33 | 1,569,827 |
| 2022-10-03 | REGN | Option Ex | 3,612 | 413.33 | 1,492,947 |
| 2022-03-21 | REGN | Option Ex | 7,439 | 380.95 | 2,833,887 |
| 2022-03-21 | REGN | Sale | 7,439 | 690.00 | 5,132,910 |
| 2022-03-17 | REGN | Sale | 7,830 | 680.00 | 5,324,400 |
| 2022-03-16 | REGN | Sale | 4,361 | 675.00 | 2,943,675 |
| 2022-03-17 | REGN | Option Ex | 7,830 | 376.69 | 2,949,482 |
| 2022-03-16 | REGN | Option Ex | 4,361 | 374.12 | 1,631,537 |
| 2021-12-09 | REGN | Sale | 3,784 | 665.00 | 2,516,360 |
| 2021-12-09 | REGN | Option Ex | 3,784 | 371.40 | 1,405,377 |
| 2021-09-13 | REGN | Option Ex | 12,750 | 273.67 | 3,489,292 |
| 2021-09-13 | REGN | Sale | 12,750 | 644.43 | 8,216,546 |
| 2020-05-06 | REGN | Option Ex | 15,000 | 177.82 | 2,667,300 |
| 2020-05-06 | REGN | Sale | 15,000 | 564.38 | 8,465,730 |
| 2020-02-13 | REGN | Sale | 14,279 | 399.58 | 5,705,574 |
| 2020-02-13 | REGN | Option Ex | 14,279 | 54.01 | 771,208 |
| 2015-08-05 | REGN | Option Ex | 5,000 | 57.11 | 285,550 |
| 2015-08-05 | REGN | Sale | 5,000 | 590.83 | 2,954,150 |
| 2014-08-27 | REGN | Sale | 3,000 | 352.20 | 1,056,600 |
| 2014-08-27 | REGN | Option Ex | 3,000 | 50.91 | 152,730 |
| 2014-08-26 | REGN | Option Ex | 1,387 | 50.91 | 70,612 |
| 2013-05-06 | REGN | Option Ex | 13,334 | 56.08 | 747,730 |
| 2013-05-06 | REGN | Sale | 13,334 | 262.11 | 3,494,934 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Tessier-lavigne Marc
(Officer of Denali Therapeutics Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.